Generics BulletinThe latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use resulted in a raft of positive opinions for the off-patent industry. After eight denosumab nods in
Pink SheetFour drugs with an orphan designation – Aucatzyl (obecabtagene autoleucel), Blenrep (belantamab mafodotin), Ezmekly (mirdametinib) and Maapliv (amino acids) – are among the 10 new products on track fo
Generics BulletinFresenius Kabi’s Tyenne (tocilizumab) biosimilar to Actemra/RoActemra is “progressing rapidly, in line with expectations, showing dynamic month-by-month growth,” following its launch in more than 20 c
Generics BulletinFresenius Kabi is set to enjoy a 14-year jump on the US patents shielding Pacira BioSciences’ Exparel (bupivacaine) liposomal injectable, albeit with a volume limit that will last for nearly a decade,